高级检索
郗玲燕, 金圭星, 张素允, 黄秀芹, 李紫玉. 齐拉西酮联合氯丙嗪治疗老年精神分裂症患者的疗效分析[J]. 实用临床医药杂志, 2021, 25(16): 116-119. DOI: 10.7619/jcmp.20211029
引用本文: 郗玲燕, 金圭星, 张素允, 黄秀芹, 李紫玉. 齐拉西酮联合氯丙嗪治疗老年精神分裂症患者的疗效分析[J]. 实用临床医药杂志, 2021, 25(16): 116-119. DOI: 10.7619/jcmp.20211029
shu
XI Lingyan, JIN Guixing, ZHANG Suyun, HUANG Xiuqin, LI Ziyu. Efficiency analysis of ziprasidone combined with chlorpromazine in treatment of elderly patients with schizophrenia[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 116-119. DOI: 10.7619/jcmp.20211029
Citation: XI Lingyan, JIN Guixing, ZHANG Suyun, HUANG Xiuqin, LI Ziyu. Efficiency analysis of ziprasidone combined with chlorpromazine in treatment of elderly patients with schizophrenia[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 116-119. DOI: 10.7619/jcmp.20211029
shu

齐拉西酮联合氯丙嗪治疗老年精神分裂症患者的疗效分析

Efficiency analysis of ziprasidone combined with chlorpromazine in treatment of elderly patients with schizophrenia

    摘要
  • 摘要:
      目的  观察齐拉西酮联合氯丙嗪治疗老年精神分裂症患者的疗效。
      方法  将100例老年精神分裂症患者随机分为对照组和联合组，每组50例。对照组采用氯丙嗪治疗，联合组采用齐拉西酮联合氯丙嗪治疗。比较2组精神症状、认知功能、神经营养因子、心电图、血钾、血镁等指标以及疗效和不良反应。
      结果  治疗后，联合组简明精神状态量表(MMSE)评分, Stroop测验、持续操作测验、数字符号编码测验评分，神经生长因子(NGF)、脑源性神经营养因子(BDNF)水平以及总有效率高于对照组，阳性与阴性症状量表(PANSS)评分、连线测验A评分以及神经元特异性烯醇化酶(NSE)、手型钙结合蛋白(S100B)、髓鞘碱性蛋白(MBP)水平低于对照组，差异均有统计学意义(P < 0.05)。
      结论  齐拉西酮联合氯丙嗪可改善老年精神分裂症患者的临床症状，纠正NGF、BDNF等神经营养因子的异常表达，修复受损神经元，且不影响患者机体电解质平衡。

     

    Abstract:
      Objective  To observe the efficacy of ziprasidone combined with chlorpromazine in the treatment of elderly patients with schizophrenia.
      Methods  Totally 100 elderly patients with schizophrenia were randomly divided into control group and combined group, with 50 cases in each group. The control group was treated with chlorpromazine, and the combined group was treated with ziprasidone and chlorpromazine. Mental symptoms, cognitive function, neurotrophic factors, electrocardiogram, blood potassium, blood magnesium and efficiency as well as adverse reactions were compared between the two groups.
      Results  After treatment, the score of Mini-mental State Examination (MMSE), the score of Stroop test, continuous operation test and digit symbol coding test, levels of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) and total effective rate in the combined group were significantly higher than those in the control group, while the score of Positive and Negative Symptom Scale (PANSS), score of connection test A and levels of neuron specific enolase (NSE), hand-type calcium binding protein (S100b) and myelin basic protein (MBP) were significantly lower than those in the control group (P < 0.05).
      Conclusion  Ziprasidone combined with chlorpromazine can improve the clinical symptoms of elderly patients with schizophrenia, the abnormal expressions of NGF, BDNF and other neurotrophic factors, repair damaged neurons, and do not affect the body electrolyte balance.

     

    • HTML全文
    • 参考文献(16)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回